# GPT4o Questions

## Domain Expert

### 1. General - GeneNetwork.org. 
<span style="color:violet">Questions in red did not receive proper answers, and were not scored.</span>

1. <span style="color:red">How have recent advancements in network-based integrative genomics altered our understanding of complex trait architectures?
2. <span style="color:red">What are the latest methodological improvements in evaluating gene-environment interactions using GeneNetwork.org?
3. How do multi-omics data integration techniques enhance the prediction accuracy of phenotypic traits in the GeneNetwork datasets?
4. What are the computational challenges and solutions for analyzing large-scale transcriptomic data on GeneNetwork.org?
5. How has the inclusion of data from diverse populations affected the generalizability of the findings on GeneNetwork.org?
6. What novel insights have been obtained from GeneNetwork.org on the genetic basis of psychiatric disorders?
7. How do advancements in machine-learning algorithms contribute to the deconvolution of gene expression data in complex tissues?
8. <span style="color:red">What role do enhancer-promoter interactions play in the regulation of gene networks uncovered through GeneNetwork.org?
9. <span style="color:red">How can the integration of ATAC-seq data with RNA-seq data from GeneNetwork.org improve chromatin accessibility and gene regulation?
1. <span style="color:red">What are the latest strategies for inferring causal relationships within gene networks using GeneNetwork.org data?
1. <span style="color:red">How do advancements in single-nucleus RNA sequencing provide insights into cell type-specific gene expression networks?
1. <span style="color:red">What impacts have recent discoveries in non-coding RNA regulation on refining gene interaction maps on GeneNetwork.org?
1. <span style="color:red">How are spatial transcriptomic approaches integrated into GeneNetwork.org to enhance the understanding of tissue architecture and function?
1. <span style="color:red">How do recent developments in quantitative trait locus (QTL) mapping refine our understanding of gene regulatory variants?"
1. <span style="color:red">What are the implications of incorporating epigenomic data such as histone modification maps into gene networks on GeneNetwork.org?
1. <span style="color:red">How have recent findings on 3D genome organization contributed to our understanding of functional genomic networks?
17. <span style="color:red">What are the potential applications of artificial intelligence in improving annotation and interpretation of gene networks?
18. <span style="color:red">How has the study of genetic pleiotropy been advanced by data available on GeneNetwork.org?
19. <span style="color:red">Novel genetic pathways related to aging and lifespan have been identified in GeneNetwork.org studies.
20. <span style="color:red">How do polygenic risk scores (PRS) developed using GeneNetwork.org data enhance the prediction and prevention of complex diseases?

### 2. Aging

1. How do recent single-cell transcriptomic studies enhance our understanding of cellular heterogeneity in aging tissues?",

2. What are the latest findings regarding the role of senescence-associated secretory phenotype (SASP) factors in age-related tissue dysfunction?

3. How do age-related changes in chromatin architecture contribute to the decline in cellular function?

4. What insights have been gained from studying epigenetic reprogramming of aged cells to a more youthful state?

5. How do alterations in the mitochondrial genome and bioenergetics influence the human aging process?

6. What are the therapeutic potentials and challenges of targeting the insulin/IGF-1 signaling pathway to extend the healthspan and lifespan?

7. How can the integration of proteomic and metabolomic data shed light on age-associated metabolic shifts?

8. Role of long non-coding RNAs (lncRNAs) in the regulation of aging and age-related diseases

9. How have recent advancements in CRISPR/Cas9 technology opened new avenues for studying and potentially reversing aging?

10. What is the significance of the DNA damage response (DDR) in the context of both replicative and chronological aging?

11. How do age-dependent changes in the immune system, such as immunosenescence, contribute to increased susceptibility to diseases?",

12. How do advancements in machine learning and artificial intelligence aid the identification of biomarkers for biological aging?

13. What recent discoveries have been made regarding the impact of systemic factors such as circulating microvesicles on aging phenotypes?

14. How do changes in the gut microbiome composition correlate with aging and longevity?

15. What are the key molecular mechanisms through which caloric restriction exerts its lifespan-extending effects across different species?

16. How does oxidative stress and the subsequent accumulation of damaged macromolecules contribute to cellular aging?

17. How are extracellular matrix remodeling and tissue stiffness implicated in the aging process?

18. Recent developments in autophagy research contribute to our understanding of its role in aging and longevity.

19. What are the implications of age-related shifts in stem cell niche composition and function on tissue regeneration capacity?

20. How do cross-linking and advanced glycation end-product (AGEs) accumulation affect the structural integrity and function of aging tissues?

### 3. Diabetes

1. How have recent advancements in multi-omics approaches, including proteomics and metabolomics, contributed to our understanding of the pathogenesis of type 2 diabetes?
2. What novel diabetic loci have been identified in the latest meta-analyses of large-scale genome-wide association studies (GWAS)?
3. How do epigenetic modifications such as DNA methylation and histone modification influence the expression of diabetes-related genes?
4. Can you elaborate on the role of the gut microbiome in modulating the genetic predispositions of the host to diabetes?
5. How effective are machine learning algorithms in integrating genomic data to predict the individual risk and progression of diabetes?
6. What are the implications of recent findings on the role of long non-coding RNAs (lncRNAs) in the regulation of insulin secretion and sensitivity?
7. How do post-translational modifications of proteins affect key signaling pathways involved in glucose homeostasis?
8. What insights have been gained from studying the genetic basis of syndromic forms of diabetes, such as Wolfram and Alstr√∂m syndromes?
9. How do genetic and epigenetic differences between monozygotic twins discordant for diabetes influence our understanding of its etiology?
10. What potential therapeutic targets have been identified in recent studies on the interaction between genetic variants and environmental factors in diabetes development?
11. How do rare variants identified through whole-genome sequencing contribute to the heritability of Type 2 diabetes?
12. What are the latest findings on the role of ncRNAs in the pathogenesis of diabetes?
13. How does the interaction between multiple polygenic risk scores (PRS) improve the prediction of type 1 and type 2 diabetes?
14. What are the mechanistic insights into beta-cell failure pathways gleaned from recent single-cell RNA-sequencing studies?
15. How does the epigenetic landscape of key metabolic tissues change in diabetic versus non-diabetic individuals?
16. What recent advancements have been made in leveraging CRISPR-based approaches to correct the monogenic forms of diabetes in vivo?
17. How do genome-wide association studies (GWAS) integrate multi-omics data to elucidate the complex genetic architecture of diabetes?
18. What is the impact of genomic imprinting on the susceptibility and progression of diabetes?
19. How do longitudinal genomics studies help in understanding gene-environment interactions in diabetes onset and management?
20. How have recent integrative genomic approaches, such as the use of single-cell RNA sequencing combined with epigenomic profiling, advanced our understanding of cellular heterogeneity and gene regulatory networks in pancreatic beta cells under diabetic conditions?